Abstract
The muscle-related complications of fasciitis and myositis, caused by chronic GVHD after Allo-SCT are relatively rare, but at times will severely impair a patient's quality of life (QOL). We performed a retrospective analysis in Japanese Allo-SCT recipients to identify the incidence, risk factors and clinical features of fasciitis and myositis. In 1967 patients who underwent Allo-SCT between January 1994 and March 2005 and survived beyond 90 days post transplantation, eight patients developed fasciitis and nine patients developed myositis, with a 5-year cumulative incidence of 0.55% and 0.54%, respectively. The median time from SCT to the development of fasciitis and myositis was 991 and 660 days, respectively. PBSCT was a risk factor for developing fasciitis, but no risk factors were found for myositis. The response to immunosuppressive treatment was better in patients with myositis than fasciitis, and the overall survival after developing these symptoms was better in patients with myositis than those with fasciitis. An early diagnosis by a biopsy, which includes fascia and muscle or magnetic resonance imaging (MRI) and prompt treatment may be important to prevent an impairment of the patient's QOL with persistent disability.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Armitage JO . Bone marrow transplantation. N Engl J Med 1994; 330: 827–838.
Atkinson K, Horowitz MM, Gale RP, van Bekkum DW, Gluckman E, Good RA et al. Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Blood 1990; 75: 2459–2464.
Farag SS . Chronic graft-versus-host disease: where do we go from here? Bone Marrow Transplant 2004; 33: 569–577.
Ozawa S, Nakaseko C, Nishimura M, Maruta A, Cho R, Ohwada C et al. Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor: incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program. Br J Haematol 2007; 137: 142–151.
Socie G, Stone JV, Wingard JR, Weisdorf D, Henslee-Downey PJ, Bredeson C et al. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. N Engl J Med 1999; 341: 14–21.
Duell T, van Lint MT, Ljungman P, Tichelli A, Socie G, Apperley JF et al. Health and functional status of long-term survivors of bone marrow transplantation. EBMT Working Party on Late Effects and EULEP Study Group on Late Effects. European Group for Blood and Marrow Transplantation. Ann Intern Med 1997; 126: 184–192.
Janin A, Socie G, Devergie A, Aractingi S, Esperou H, Verola O et al. Fasciitis in chronic graft-versus-host disease. A clinicopathologic study of 14 cases. Ann Intern Med 1994; 120: 993–998.
Markusse HM, Dijkmans BA, Fibbe WE . Eosinophilic fasciitis after allogeneic bone marrow transplantation. J Rheumatol 1990; 17: 692–694.
van den Bergh V, Tricot G, Fonteyn G, Dom R, Bulcke J . Diffuse fasciitis after bone marrow transplantation. Am J Med 1987; 83: 139–143.
Parker P, Chao NJ, Ben-Ezra J, Slatkin N, Openshaw H, Niland JC et al. Polymyositis as a manifestation of chronic graft-versus-host disease. Medicine (Baltimore) 1996; 75: 279–285.
Stevens AM, Sullivan KM, Nelson JL . Polymyositis as a manifestation of chronic graft-versus-host disease. Rheumatology (Oxford) 2003; 42: 34–39.
Couriel DR, Beguelin GZ, Giralt S, De Lima M, Hosing C, Kharfan-Dabaja MA et al. Chronic graft-versus-host disease manifesting as polymyositis: an uncommon presentation. Bone Marrow Transplant 2002; 30: 543–546.
Tse S, Saunders EF, Silverman E, Vajsar J, Becker L, Meaney B . Myasthenia gravis and polymyositis as manifestations of chronic graft-versus-host-disease. Bone Marrow Transplant 1999; 23: 397–399.
Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945–956.
Bohan A, Peter JB . Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975; 292: 344–347.
Bohan A, Peter JB . Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975; 292: 403–407.
Kaplan EL, Meier P . Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–481.
Gray RJ . A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988; 16: 1141–1154.
Goldstein R, Duvic M, Targoff IN, Reichlin M, McMenemy AM, Reveille JD et al. HLA-D region genes associated with autoantibody responses to histidyl-transfer RNA synthetase (Jo-1) and other translation-related factors in myositis. Arthritis Rheum 1990; 33: 1240–1248.
Sato N, Okamoto S, Mori T, Watanabe R, Hamano Y, Kawamura J et al. Recurrent acute myositis after allogeneic bone marrow transplantation for myelodysplasia. Hematology 2002; 7: 109–112.
Flowers ME, Parker PM, Johnston LJ, Matos AV, Storer B, Bensinger WI et al. Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial. Blood 2002; 100: 415–419.
Atsuta Y, Suzuki R, Yamamoto K, Terakura S, Iida H, Kohno A et al. Risk and prognostic factors for Japanese patients with chronic graft-versus-host disease after bone marrow transplantation. Bone Marrow Transplant 2006; 37: 289–296.
Akpek G, Lee SJ, Flowers ME, Pavletic SZ, Arora M, Lee S et al. Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter study. Blood 2003; 102: 802–809.
Kojima K, Kurokawa MS, Tanimoto K, Kojima Y, Hara M, Yoshino T et al. Clonal expansion of limited T cell clonotypes in affected muscle from a patient with post-transplant polymyositis. Bone Marrow Transplant 2002; 30: 467–470.
Leano AM, Miller K, White AC . Chronic graft-versus-host disease-related polymyositis as a cause of respiratory failure following allogeneic bone marrow transplant. Bone Marrow Transplant 2000; 26: 1117–1120.
Stephenson AL, Mackenzie IR, Levy RD, Road J . Myositis associated graft-versus-host-disease presenting as respiratory muscle weakness. Thorax 2001; 56: 82–84.
Ustun C, Ho Jr G . Eosinophilic fasciitis after allogeneic stem cell transplantation: a case report and review of the literature. Leuk Lymphoma 2004; 45: 1707–1709.
Author information
Authors and Affiliations
Consortia
Corresponding author
Rights and permissions
About this article
Cite this article
Oda, K., Nakaseko, C., Ozawa, S. et al. Fasciitis and myositis: an analysis of muscle-related complications caused by chronic GVHD after allo-SCT. Bone Marrow Transplant 43, 159–167 (2009). https://doi.org/10.1038/bmt.2008.297
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2008.297
Keywords
This article is cited by
-
Graft versus host disease-related eosinophilic fasciitis: cohort description and literature review
Advances in Rheumatology (2022)
-
Eosinophilic fasciitis (Shulman syndrome), a rare entity and diagnostic challenge, as a manifestation of severe chronic graft-versus-host disease: a case report
Journal of Medical Case Reports (2021)
-
Clinical Characteristics of Myositis Associated with Graft-Versus-Host Disease
Current Rheumatology Reports (2021)
-
Real-world study of direct medical and indirect costs and time spent in healthcare in patients with chronic graft versus host disease
The European Journal of Health Economics (2021)
-
EBMT−NIH−CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment
Bone Marrow Transplantation (2018)